Press Releases :: Aethlon Medical, Inc. (AEMD)

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Year

Category

Oct 30, 2017

Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017

Oct 16, 2017

Aethlon Medical Announces Large-Scale Production Collaboration

Oct 11, 2017

Aethlon Medical to Present at the 2017 BIO Investor Forum

Oct 10, 2017

Aethlon Medical Announces Compliance With Nasdaq Listing Criteria

Oct 2, 2017

Aethlon Medical Announces Pricing of $6 Million Public Offering

Sep 14, 2017

Aethlon Medical Receives National Cancer Institute Contract Award

Sep 12, 2017

Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses

Sep 6, 2017

Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017

Aug 10, 2017

Aethlon Medical Announces Fiscal 2018 First Quarter Results

Aug 3, 2017

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017

rss_feed News RSS